back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2020-07-09 17:19 Tx date 2020-07-01 |
$NXG
NexgenRx Inc. |
Loucks, Ronald Campbell
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Preferred Shares Series 1
11 - Acquisition or disposition carried out privately
|
$200,000
+800,000 vol $0.25 each |
800,000 | |
| Filed 2020-07-09 17:17 Tx date 2006-08-28 |
$NXG
NexgenRx Inc. |
Loucks, Ronald Campbell
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Preferred Shares Series 1
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-12-10 Tx date 2018-12-06 |
$NXG
NexgenRx Inc. |
Loucks, Ronald Campbell
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+2,000,000 vol |
4,400,275 | |
| Filed 2018-10-14 Tx date 2018-10-12 |
$NXG
NexgenRx Inc. |
Loucks, Ronald Campbell
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$15,000
+60,000 vol $0.25 each |
7,335,108 | |
| Filed 2018-01-01 Tx date 2017-12-29 |
$NXG
NexgenRx Inc. |
Loucks, Ronald Campbell
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$59,393
+237,575 vol $0.25 each |
7,275,108 | |
| Filed 2017-09-29 Tx date 2017-09-29 |
$NXG
NexgenRx Inc. |
Loucks, Ronald Campbell
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$230,000
+1,000,000 vol $0.23 each |
2,400,275 | |
| Filed 2016-12-31 Tx date 2016-12-30 |
$NXG
NexgenRx Inc. |
Loucks, Ronald Campbell
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$60,000
+300,000 vol $0.20 each |
7,037,533 | |
| Filed 2016-07-29 Tx date 2016-07-29 |
$NXG
NexgenRx Inc. |
Loucks, Ronald Campbell
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$16,000
+100,000 vol $0.16 each |
6,737,533 | |
| Filed 2015-09-25 Tx date 2015-09-23 |
$NXG
NexgenRx Inc. |
Loucks, Ronald Campbell
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$15,000
+100,000 vol $0.15 each |
6,637,533 | |
| Filed 2015-07-02 Tx date 2015-06-30 |
$NXG
NexgenRx Inc. |
Loucks, Ronald Campbell
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$102,000
+600,000 vol $0.17 each |
6,237,533 | |
| Filed 2015-07-02 Tx date 2015-06-30 |
$NXG
NexgenRx Inc. |
Loucks, Ronald Campbell
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
53 - Grant of warrants
|
$60,000
+300,000 vol $0.20 each |
6,537,533 |